Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Halo Labs, Inc. was a life science instrumentation company that specialized in developing and commercializing tools for biopharmaceutical particle analysis and aggregate testing. Their core offering, the Aura™ platform (including Aura, Aura GT, Aura CL, Aura PTI), provided high-throughput, low-volume subvisible particle analysis, playing a crucial role in drug product development, formulation, and quality control. The company aimed to address the challenges of characterizing and ensuring the stability of biologic drugs. Halo Labs was acquired by Catalent in December 2021, and its technologies are now part of Catalent's biologics analytical services.
The Burlingame headquarters served as the central hub for all company operations, including research and development, instrument manufacturing, global sales and marketing, customer support, and corporate administration.
The facility likely included specialized laboratory spaces for instrument development, testing, and sample analysis, alongside modern office spaces. Its location offered access to a rich talent pool and a vibrant biotech ecosystem.
As an innovative life science instrumentation company, Halo Labs likely fostered a work culture characterized by scientific rigor, collaboration, customer-centricity, and a fast-paced environment focused on solving complex analytical challenges in biopharmaceutical development.
The headquarters was critical for Halo Labs' innovation and growth, enabling the development of its Aura™ platform and facilitating its market penetration. Proximity to other biotech firms and research institutions was also beneficial.
Before its acquisition, Halo Labs served a global customer base, with its Aura™ particle analysis systems utilized by pharmaceutical and biotechnology companies, as well as contract research organizations (CROs) and academic institutions in North America, Europe, and Asia-Pacific. Their global reach was supported by a direct sales and support team and a network of distribution partners in various regions.
700 Airport Blvd, Suite 330
Burlingame
California
USA
Address: N/A - Remote/Field Operations
These field teams were responsible for direct customer engagement, product demonstrations, installation, training, after-sales support, and gathering regional market intelligence for Halo Labs' particle analysis instruments.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Halo Labs' leadership includes:
Halo Labs has been backed by several prominent investors over the years, including:
Halo Labs was acquired by Catalent in December 2021 and ceased to operate as an independent entity. Consequently, there have been no executive new hires or exits attributable to 'Halo Labs' as a standalone company in the last 12 months. Any leadership changes related to former Halo Labs personnel would now occur within the Catalent organizational structure.
Discover the tools Halo Labs uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition, Halo Labs likely utilized standard corporate email address formats. The most common patterns for companies of its nature are [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com]. Emails to @halolabs.com are no longer active for the independent entity.
[first_initial][last]@halolabs.com (e.g., jdoe@halolabs.com) or [first].[last]@halolabs.com (e.g., jane.doe@halolabs.com)
Format
rwicke@halolabs.com
Example
0 (domain inactive/redirected post-acquisition for independent entity)%
Success rate
Catalent Official Website • December 1, 2021
Catalent announced the completion of its acquisition of Halo Labs, a specialist in membrane-based particle analysis and aggregation systems. This acquisition aimed to enhance Catalent's capabilities in biologic drug development and analytical services....more
Business Wire • June 2, 2020
Halo Labs announced the launch of Aura PTI™, a particle identification instrument designed to perform subvisible particle analysis and identify particle types, further expanding its Aura platform for biopharmaceutical characterization....more
PR Newswire • October 10, 2018
Halo Labs secured $5.5 million in Series B financing. The funding round was led by Research Corporation Technologies (RCT) and included existing investors BioAdvance and BroadOak Capital Partners, aimed at accelerating product development and commercial expansion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Halo Labs, are just a search away.